The Oxford-AstraZeneca COVID-19 vaccine has 3 key advantages despite lower efficacy rate
The United Kingdom on Wednesday authorized the COVID-19 vaccine developed by the University of Oxford and AstraZeneca for use, joining the Pfizer-BioNTech shot, which has already been rolled out, as another tool in the country's massive vaccination drive. U.K. Health Secretary Matt Hanock said enough doses of both vaccines are on order to give the entire population two jabs, and he's "highly confident that we can get enough vulnerable people vaccinated by the spring that we can now see our route... Читать дальше...